Back

NOTCH1 drives tumor plasticity and metastasis in hepatocellular carcinoma

Lindblad, K. E.; Donne, R.; Liebling, I.; Bresnahan, E.; Barcena-Varela, M.; Lozano, A.; Park, E.; Giotti, B.; Burn, O.; Fiel, M. I.; Bravo-Cordero, J. J.; Tsankov, A. M.; Lujambio, A.

2024-10-27 cancer biology
10.1101/2024.10.23.619856 bioRxiv
Show abstract

Background & AimsLiver cancer, the third leading cause of cancer-related mortality worldwide, has two main subtypes: hepatocellular carcinoma (HCC), accounting the majority of the cases, and cholangiocarcinoma (CAA). Notch pathway primarily regulates the intrahepatic development of bile ducts, which are lined with cholangiocytes, but it can also be upregulated in 1/3 of HCCs. To better understand the role of NOTCH1 in HCC, we developed a novel mouse model driven by activated Notch1 intracellular domain (NICD1) and MYC overexpression in hepatocytes. MethodsUsing the hydrodynamic tail-vein injection method for establishing primary liver tumors, we generated a novel murine model of liver cancer harboring MYC overexpression and NOTCH1 activation. We characterized this model histopathologically as well as transcriptomically, utilizing both bulk and single cell RNA-sequencing. We also performed functional experiments using monoclonal antibodies. ResultsMYC;NICD1 tumors displayed a combined HCC-CCA phenotype with temporal plasticity. At early time-points, histology was predominantly "cholangiocellular", which then progressed to mainly "hepatocellular". The "hepatocellular" component was enriched in mesenchymal genes and gave rise to lung metastasis. Metastatic cells were enriched in the TGFB and VEGF pathways and their inhibition significantly reduced the metastatic burden. ConclusionsOur novel mouse model uncovered NOTCH1 as a driver of temporal plasticity and metastasis in HCC, the latter of which is, in part, mediated by angiogenesis and TGF{beta} pathways. Impact and ImplicationsThis study develops a novel murine model of NOTCH1-driven liver cancer, an understudied oncogene in HCC. Using this model, we show that NOTCH1 drives plasticity in HCC and metastasis to the lungs that can be therapeutically targeted through inhibition of VEGF and TGF{beta} pathways. HighlightsO_LINOTCH1 activation in combination with MYC overexpression drives combined HCC-CCA. C_LIO_LINOTCH1 activation in hepatocytes drives temporal plasticity. C_LIO_LINOTCH1 activation drives metastasis of HCC cells to the lungs, but not of CCA cells. C_LIO_LIAngiogenesis and TGF{beta} pathways mediate NOTCH1-induced lung metastasis. C_LI Graphical abstract O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=93 SRC="FIGDIR/small/619856v2_ufig1.gif" ALT="Figure 1"> View larger version (39K): org.highwire.dtl.DTLVardef@143c866org.highwire.dtl.DTLVardef@119ddb6org.highwire.dtl.DTLVardef@12ad951org.highwire.dtl.DTLVardef@2160b8_HPS_FORMAT_FIGEXP M_FIG C_FIG

Matching journals

The top 6 journals account for 50% of the predicted probability mass.

1
Hepatology
18 papers in training set
Top 0.1%
17.5%
2
Cancers
200 papers in training set
Top 0.3%
12.3%
3
British Journal of Cancer
42 papers in training set
Top 0.2%
6.8%
4
Frontiers in Oncology
95 papers in training set
Top 0.6%
6.3%
5
Hepatology Communications
21 papers in training set
Top 0.1%
6.3%
6
PLOS Computational Biology
1633 papers in training set
Top 10%
3.6%
50% of probability mass above
7
Gut
36 papers in training set
Top 0.3%
2.9%
8
BMC Cancer
52 papers in training set
Top 0.9%
2.6%
9
International Journal of Cancer
42 papers in training set
Top 0.5%
2.1%
10
BMC Medicine
163 papers in training set
Top 3%
1.8%
11
Journal of Hepatology
18 papers in training set
Top 0.2%
1.7%
12
PeerJ
261 papers in training set
Top 7%
1.7%
13
PLOS ONE
4510 papers in training set
Top 54%
1.7%
14
Scientific Reports
3102 papers in training set
Top 58%
1.7%
15
Clinical Cancer Research
58 papers in training set
Top 1%
1.3%
16
Biology Methods and Protocols
53 papers in training set
Top 1%
1.3%
17
Journal of Translational Medicine
46 papers in training set
Top 1%
1.3%
18
Neoplasia
22 papers in training set
Top 0.4%
1.2%
19
Cellular and Molecular Gastroenterology and Hepatology
41 papers in training set
Top 0.5%
0.9%
20
eLife
5422 papers in training set
Top 52%
0.9%
21
Nature Communications
4913 papers in training set
Top 60%
0.9%
22
F1000Research
79 papers in training set
Top 4%
0.8%
23
Gastroenterology
40 papers in training set
Top 2%
0.8%
24
EMBO Molecular Medicine
85 papers in training set
Top 4%
0.8%
25
Molecular and Cellular Biology
40 papers in training set
Top 0.3%
0.8%
26
The Journal of Pathology
22 papers in training set
Top 0.5%
0.7%
27
American Journal of Physiology-Gastrointestinal and Liver Physiology
11 papers in training set
Top 0.2%
0.7%
28
Biomolecules
95 papers in training set
Top 2%
0.7%
29
Cell Reports
1338 papers in training set
Top 34%
0.7%
30
Translational Oncology
18 papers in training set
Top 0.5%
0.6%